{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T02:24:26Z","timestamp":1786933466063,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":69,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biosci"],"DOI":"10.1186\/s13578-026-01573-4","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T19:05:13Z","timestamp":1781031913000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["RNF214 silencing attenuates prostate cancer progression and modulates mTOR signaling through CAV1 ubiquitination"],"prefix":"10.1186","volume":"16","author":[{"given":"Zongqiang","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiming","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangfan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"issue":"7","key":"1573_CR1","doi-asserted-by":"publisher","first-page":"256","DOI":"10.31083\/j.fbl2907256","volume":"29","author":"LV Duy","year":"2024","unstructured":"Duy LV, et al. Associations of CYLD, JAK2 and TLR4 genotypes with PSA levels and immunophenotype in benign prostatic hyperplasia and prostate cancer. Front Biosci (Landmark Ed). 2024;29(7):256.","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"10","key":"1573_CR2","doi-asserted-by":"publisher","first-page":"360","DOI":"10.31083\/j.fbl2910360","volume":"29","author":"Y Wang","year":"2024","unstructured":"Wang Y, et al. Study of the role of E2F1 and TMEM132A in prostate cancer development. Front Biosci (Landmark Ed). 2024;29(10):360.","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"12","key":"1573_CR3","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1056\/NEJMoa2107322","volume":"385","author":"O Sartor","year":"2021","unstructured":"Sartor O, et al. Lutetium-177-PSMA-617 for metastatic castration-resistant prostate cancer. N Engl J Med. 2021;385(12):1091\u2013103.","journal-title":"N Engl J Med"},{"key":"1573_CR4","doi-asserted-by":"crossref","unstructured":"Sharifi N et al. Survival of men with metastatic hormone-sensitive prostate cancer and adrenal-permissive HSD3B1 inheritance. J Clin Invest, 2024. 134(18).","DOI":"10.1172\/JCI183583"},{"key":"1573_CR5","doi-asserted-by":"crossref","unstructured":"\u00c7etin G et al. The ubiquitin-proteasome system in immune cells. Biomolecules, 2021;11(1).","DOI":"10.3390\/biom11010060"},{"issue":"3","key":"1573_CR6","doi-asserted-by":"publisher","first-page":"e1204","DOI":"10.1002\/ctm2.1204","volume":"13","author":"C Sampson","year":"2023","unstructured":"Sampson C, et al. The roles of E3 ubiquitin ligases in cancer progression and targeted therapy. Clin Transl Med. 2023;13(3):e1204.","journal-title":"Clin Transl Med"},{"key":"1573_CR7","doi-asserted-by":"crossref","unstructured":"Toma-Fukai S, Shimizu T. Structural diversity of ubiquitin E3 ligase. Molecules, 2021;26(21).","DOI":"10.3390\/molecules26216682"},{"issue":"Suppl 3","key":"1573_CR8","doi-asserted-by":"publisher","first-page":"S1984","DOI":"10.4103\/jpbs.jpbs_134_24","volume":"16","author":"A Jamal","year":"2024","unstructured":"Jamal A. E3 Ubiquitin ligases and their therapeutic applications in cancers: narrative review. J Pharm Bioallied Sci. 2024;16(Suppl 3):S1984\u20136.","journal-title":"J Pharm Bioallied Sci"},{"key":"1573_CR9","doi-asserted-by":"publisher","first-page":"103217","DOI":"10.1016\/j.dnarep.2021.103217","volume":"108","author":"BR Chen","year":"2021","unstructured":"Chen BR, et al. The RNF8 and RNF168 ubiquitin ligases regulate pro- and anti-resection activities at broken DNA ends during non-homologous end joining. DNA Repair (Amst). 2021;108:103217.","journal-title":"DNA Repair (Amst)"},{"issue":"6742","key":"1573_CR10","doi-asserted-by":"publisher","first-page":"eads4539","DOI":"10.1126\/science.ads4539","volume":"388","author":"M Kim","year":"2025","unstructured":"Kim M, et al. Exogenous RNA surveillance by proton-sensing TRIM25. Science. 2025;388(6742):eads4539.","journal-title":"Science"},{"issue":"1","key":"1573_CR11","doi-asserted-by":"publisher","first-page":"7656","DOI":"10.1038\/s41467-023-43326-8","volume":"14","author":"O Barroso-Gomila","year":"2023","unstructured":"Barroso-Gomila O, et al. BioE3 identifies specific substrates of ubiquitin E3 ligases. Nat Commun. 2023;14(1):7656.","journal-title":"Nat Commun"},{"issue":"1","key":"1573_CR12","doi-asserted-by":"publisher","first-page":"4995","DOI":"10.1038\/s41467-024-49045-y","volume":"15","author":"M Lin","year":"2024","unstructured":"Lin M, et al. The RNF214-TEAD-YAP signaling axis promotes hepatocellular carcinoma progression via TEAD ubiquitylation. Nat Commun. 2024;15(1):4995.","journal-title":"Nat Commun"},{"issue":"6","key":"1573_CR13","doi-asserted-by":"publisher","first-page":"189002","DOI":"10.1016\/j.bbcan.2023.189002","volume":"1878","author":"S Bhowmick","year":"2023","unstructured":"Bhowmick S, et al. Caveolin-1 and lipids: association and their dualism in oncogenic regulation. Biochim Biophys Acta Rev Cancer. 2023;1878(6):189002.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"10","key":"1573_CR14","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1007\/s00268-017-4065-9","volume":"41","author":"B Torrej\u00f3n","year":"2017","unstructured":"Torrej\u00f3n B, et al. Caveolin-1 is markedly downregulated in patients with early-stage colorectal cancer. World J Surg. 2017;41(10):2625\u201330.","journal-title":"World J Surg"},{"issue":"6","key":"1573_CR15","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/iep.12394","volume":"102","author":"M Aliyari","year":"2021","unstructured":"Aliyari M, et al. The role of caveolin-1 and endothelial nitric oxide synthase polymorphisms in susceptibility to prostate cancer. Int J Exp Pathol. 2021;102(6):260\u20137.","journal-title":"Int J Exp Pathol"},{"issue":"9","key":"1573_CR16","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1080\/15548627.2020.1820787","volume":"17","author":"N Ariotti","year":"2021","unstructured":"Ariotti N, et al. An inverted CAV1 (caveolin 1) topology defines novel autophagy-dependent exosome secretion from prostate cancer cells. Autophagy. 2021;17(9):2200\u201316.","journal-title":"Autophagy"},{"key":"1573_CR17","doi-asserted-by":"publisher","first-page":"562774","DOI":"10.3389\/fonc.2020.562774","volume":"10","author":"P Chen","year":"2020","unstructured":"Chen P, et al. Association of Caveolin-1 expression with prostate cancer: a systematic review and meta-analysis. Front Oncol. 2020;10:562774.","journal-title":"Front Oncol"},{"issue":"1","key":"1573_CR18","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s12672-023-00813-0","volume":"14","author":"Q Bian","year":"2023","unstructured":"Bian Q, et al. Molecular pathogenesis, mechanism and therapy of Cav1 in prostate cancer. Discov Oncol. 2023;14(1):196.","journal-title":"Discov Oncol"},{"key":"1573_CR19","doi-asserted-by":"crossref","unstructured":"Dalton CM, Schlegel C, Hunter CJ. Caveolin-1: a review of intracellular functions, tissue-specific roles, and epithelial tight junction regulation. Volume 12. Biology (Basel); 2023. 11.","DOI":"10.3390\/biology12111402"},{"key":"1573_CR20","doi-asserted-by":"publisher","first-page":"15502","DOI":"10.1038\/ncomms15502","volume":"8","author":"CY Lee","year":"2017","unstructured":"Lee CY, et al. The ubiquitin ligase ZNRF1 promotes caveolin-1 ubiquitination and degradation to modulate inflammation. Nat Commun. 2017;8:15502.","journal-title":"Nat Commun"},{"key":"1573_CR21","doi-asserted-by":"crossref","unstructured":"Choi J et al. RNF213 acts as a molecular switch for Cav-1 ubiquitination and phosphorylation in human cells. Cells 2025;14(11).","DOI":"10.3390\/cells14110775"},{"key":"1573_CR22","doi-asserted-by":"crossref","unstructured":"Fu W, Wu G. Targeting mTOR for anti-aging and anti-cancer therapy. Molecules 2023;28(7).","DOI":"10.3390\/molecules28073157"},{"key":"1573_CR23","doi-asserted-by":"publisher","first-page":"774103","DOI":"10.3389\/fimmu.2021.774103","volume":"12","author":"S Mafi","year":"2021","unstructured":"Mafi S, et al. mTOR-mediated regulation of immune responses in cancer and tumor microenvironment. Front Immunol. 2021;12:774103.","journal-title":"Front Immunol"},{"key":"1573_CR24","doi-asserted-by":"crossref","unstructured":"Mir SA et al. Exploring the mTOR signalling pathway and its inhibitory scope in cancer. Pharmaceuticals (Basel) 2023;16(7).","DOI":"10.3390\/ph16071004"},{"issue":"8","key":"1573_CR25","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/s43018-023-00594-z","volume":"4","author":"D Brina","year":"2023","unstructured":"Brina D, et al. The Akt\/mTOR and MNK\/eIF4E pathways rewire the prostate cancer translatome to secrete HGF, SPP1 and BGN and recruit suppressive myeloid cells. Nat Cancer. 2023;4(8):1102\u201321.","journal-title":"Nat Cancer"},{"issue":"12","key":"1573_CR26","doi-asserted-by":"publisher","first-page":"110534","DOI":"10.1016\/j.celrep.2022.110534","volume":"38","author":"CR Dufour","year":"2022","unstructured":"Dufour CR, et al. The mTOR chromatin-bound interactome in prostate cancer. Cell Rep. 2022;38(12):110534.","journal-title":"Cell Rep"},{"issue":"7","key":"1573_CR27","doi-asserted-by":"publisher","first-page":"166129","DOI":"10.1016\/j.bbadis.2021.166129","volume":"1867","author":"V Makwana","year":"2021","unstructured":"Makwana V, Rudrawar S, Anoopkumar-Dukie S. Signalling transduction of O-GlcNAcylation and PI3K\/AKT\/mTOR-axis in prostate cancer. Biochim Biophys Acta Mol Basis Dis. 2021;1867(7):166129.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"25","key":"1573_CR28","doi-asserted-by":"publisher","first-page":"40843","DOI":"10.18632\/oncotarget.17257","volume":"8","author":"J Wu","year":"2017","unstructured":"Wu J, et al. High glucose induces formation of tau hyperphosphorylation via Cav-1-mTOR pathway: a potential molecular mechanism for diabetes-induced cognitive dysfunction. Oncotarget. 2017;8(25):40843\u201356.","journal-title":"Oncotarget"},{"key":"1573_CR29","doi-asserted-by":"publisher","first-page":"172910","DOI":"10.1016\/j.ejphar.2020.172910","volume":"871","author":"W Xue","year":"2020","unstructured":"Xue W, et al. Caveolin-1 alleviates lipid accumulation in NAFLD associated with promoting autophagy by inhibiting the Akt\/mTOR pathway. Eur J Pharmacol. 2020;871:172910.","journal-title":"Eur J Pharmacol"},{"issue":"13","key":"1573_CR30","doi-asserted-by":"publisher","first-page":"16227","DOI":"10.18632\/oncotarget.7583","volume":"7","author":"H Yang","year":"2016","unstructured":"Yang H, et al. Mechanosensitive caveolin-1 activation-induced PI3K\/Akt\/mTOR signaling pathway promotes breast cancer motility, invadopodia formation and metastasis in vivo. Oncotarget. 2016;7(13):16227\u201347.","journal-title":"Oncotarget"},{"issue":"49","key":"1573_CR31","doi-asserted-by":"publisher","first-page":"e36473","DOI":"10.1097\/MD.0000000000036473","volume":"102","author":"L Guo","year":"2023","unstructured":"Guo L, et al. CAV1 and KRT5 are potential targets for prostate cancer. Med (Baltim). 2023;102(49):e36473.","journal-title":"Med (Baltim)"},{"key":"1573_CR32","doi-asserted-by":"crossref","unstructured":"Yin D et al. CAV1 is a prognostic predictor for patients with idiopathic pulmonary fibrosis and lung cancer. J Biosci 2022;47.","DOI":"10.1007\/s12038-021-00245-4"},{"issue":"11","key":"1573_CR33","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1038\/s12276-023-01109-7","volume":"55","author":"N Hwang","year":"2023","unstructured":"Hwang N, et al. Caveolin-1 mediates the utilization of extracellular proteins for survival in refractory gastric cancer. Exp Mol Med. 2023;55(11):2461\u201372.","journal-title":"Exp Mol Med"},{"issue":"5","key":"1573_CR34","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.7150\/thno.79250","volume":"13","author":"Y Wang","year":"2023","unstructured":"Wang Y, et al. Tumor-derived Cav-1 promotes pre-metastatic niche formation and lung metastasis in breast cancer. Theranostics. 2023;13(5):1684\u201397.","journal-title":"Theranostics"},{"key":"1573_CR35","doi-asserted-by":"publisher","first-page":"102149","DOI":"10.1016\/j.tranon.2024.102149","volume":"50","author":"W Liu","year":"2024","unstructured":"Liu W, Luo G. CAV1 inhibits Xc(-) system through IFNGR1 to promote ferroptosis to inhibit stemness and improves anti-PD-1 efficacy in breast cancer. Transl Oncol. 2024;50:102149.","journal-title":"Transl Oncol"},{"issue":"37","key":"1573_CR36","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1038\/s41388-024-03124-y","volume":"43","author":"D Li","year":"2024","unstructured":"Li D, et al. Hypoxia-induced LAMB2-enriched extracellular vesicles promote peritoneal metastasis in gastric cancer via the ROCK1-CAV1-Rab11 axis. Oncogene. 2024;43(37):2768\u201380.","journal-title":"Oncogene"},{"key":"1573_CR37","doi-asserted-by":"crossref","unstructured":"Roudsari NM et al. Inhibitors of the PI3K\/Akt\/mTOR pathway in prostate cancer chemoprevention and intervention. Pharmaceutics 2021;13(8).","DOI":"10.3390\/pharmaceutics13081195"},{"key":"1573_CR38","doi-asserted-by":"crossref","unstructured":"Shorning BY et al. The PI3K-AKT-mTOR pathway and prostate cancer: at the crossroads of AR, MAPK, and WNT signaling. Int J Mol Sci 2020;21(12).","DOI":"10.3390\/ijms21124507"},{"key":"1573_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcancer.2019.12.008","volume":"80","author":"D Tewari","year":"2022","unstructured":"Tewari D, et al. Natural products targeting the PI3K-Akt-mTOR signaling pathway in cancer: a novel therapeutic strategy. Semin Cancer Biol. 2022;80:1\u201317.","journal-title":"Semin Cancer Biol"},{"issue":"6","key":"1573_CR40","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1080\/15548627.2019.1659613","volume":"16","author":"X Bai","year":"2020","unstructured":"Bai X, et al. CAV1-CAVIN1-LC3B-mediated autophagy regulates high glucose-stimulated LDL transcytosis. Autophagy. 2020;16(6):1111\u201329.","journal-title":"Autophagy"}],"container-title":["Cell &amp; Bioscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13578-026-01573-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13578-026-01573-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13578-026-01573-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T01:40:47Z","timestamp":1786930847000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13578-026-01573-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1573"],"URL":"https:\/\/doi.org\/10.1186\/s13578-026-01573-4","relation":{},"ISSN":["2045-3701"],"issn-type":[{"value":"2045-3701","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,9]]},"assertion":[{"value":"26 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the animal ethics committee of the Sanming First Hospital Affiliated to Fujian Medical University with approval number 2025-92.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":3,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"91"}}